Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Tapentadol

A centrally acting analgesic, approved in the United States in 2008 to relieve moderate to severe acute pain: it acts in the central nervous system by reducing the transmission of pain signals. This family brings together the active ingredient, pharmacopoeial impurities, nitrosamines and other impurities.

Did you know?It combines two mechanisms in a single molecule: it activates mu opioid receptors and blocks noradrenaline reuptake, as some antidepressants do.

TapentadolGo to the active ingredient →
TapentadolActive ingredientTapentadolCat. No. P-T017-001CAS 175591-23-8

EDQM standards 2

The official European Pharmacopoeia standards for this family.

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.